Introduction Despite international consensus and clearly written guidelines urging wider use
of corticosteroids or combinations of inhaled short-and long-acting β-agonists (SABA and …

Despite limited evidence on safety and efficacy of drug use in neonates, drugs are
extensively used in this age group. However, the availability of information on drug …

Purpose Validated measures of asthma and eczema at the population level remain a
challenge. Our aim was to ascertain if register‐based information on asthma/eczema …

Background and objective To provide an overview of drug use in outpatient children in
France, a population-based study using a national reimbursement claims database …

Background Inhalation corticosteroids (ICS) are prescribed for treatment of asthma in
approximately 3% of all children in Denmark. Despite limited evidence, case reports suggest …

To cite this article: Arellano FM, Arana A, Wentworth CE, Vidaurre CF, Chipps BE.
Prescription patterns for asthma medications in children and adolescents with health care …

Background Large differences exist in the prevalence rate of drugs prescribed to children
and adolescents between and within countries. The aim of this study was to evaluate child …

Respiratory drugs are widely used in children to treat labeled and non-labeled indications
but only some data are available quantifying comprehensively off-label usage. Thus, we aim …

Although montelukast is claimed to be preferable to inhaled corticosteroids in children with
asthma and allergic rhinitis, virus-induced exacerbations, exercise induced asthma, and in …

Purpose: Inhaled Corticosteroids (ICSs) and oral Leukotriene Receptor Antagonists (LTRAs)
are commonly prescribed asthma preventers, however, concerns have been raised as to …